Shares Magazine
13.25p+0.25 (+-0.54%)07 Nov 2025, 13:20
Jump to:
Rua Life Sciences PLC Fundamentals
| Company Name | Rua Life Sciences PLC | Last Updated | 2025-11-07 |
|---|---|---|---|
| Industry | Medical Devices | Sector | Healthcare |
| Shares in Issue | 62.060 m | Market Cap | £8.22 m |
| PE Ratio | 10.17 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | 0 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.1112 | Debt Equity Ratio | 0.0876 |
| Asset Equity Ratio | 1.2520 | Cash Equity Ratio | 0.4825 |
| Quick Ratio | 4.2278 | Current Ratio | 4.91 |
| Price To Book Value | 1.1268 | ROCE | 0 |
Rua Life Sciences PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Rua Life Sciences PLC Company Financials
| Assets | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Tangible Assets | £3.17 m | £2.46 m | £2.74 m | £2.60 m |
| Intangible Assets | £676,000.00 | £720,000.00 | £771,000.00 | £822,000.00 |
| Investments | 0 | 0 | 0 | 0 |
| Total Fixed Assets | £3.84 m | £3.18 m | £3.51 m | £3.42 m |
| Stocks | £754,000.00 | £112,000.00 | £81,000.00 | £124,000.00 |
| Debtors | £1.09 m | £761,000.00 | £422,000.00 | £915,000.00 |
| Cash & Equivalents | £3.57 m | £3.93 m | £1.48 m | £2.96 m |
| Other Assets | 0 | 0 | 0 | 0 |
| Total Assets | £9.26 m | £8.17 m | £5.66 m | £7.63 m |
| Liabilities | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Creditors within 1 year | £1.10 m | £554,000.00 | £414,000.00 | £511,000.00 |
| Creditors after 1 year | £761,000.00 | £433,000.00 | £566,000.00 | £531,000.00 |
| Other Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | £1.86 m | £987,000.00 | £980,000.00 | £1.04 m |
| Net assets | £7.39 m | £7.18 m | £4.68 m | £6.58 m |
| Equity | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Called up share capital | £3.10 m | £3.10 m | £1.11 m | £1.11 m |
| Share Premium | £25.55 m | £25.55 m | £23.57 m | £23.57 m |
| Profit / Loss | -£10,000.00 | -£2.02 m | -£2.32 m | -£2.36 m |
| Other Equity | £7.30 m | £7.18 m | £4.68 m | £6.58 m |
| Preference & Minorities | £94,000.00 | 0 | 0 | 0 |
| Total Capital Employed | £7.39 m | £7.18 m | £4.68 m | £6.58 m |
| Ratios | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Debt Ratio | £0.08 | £0.04 | £0.07 | £0.04 |
| Debt-to-Equity | £0.09 | £0.04 | £0.08 | £0.04 |
| Assets / Equity | 1.2520 | 1.2520 | 1.2520 | 1.2520 |
| Cash / Equity | 0.4825 | 0.4825 | 0.4825 | 0.4825 |
| EPS | 0 | -£0.04 | -£0.09 | -£0.09 |
| Cash Flow | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash from operating activities | -£219,000.00 | -£1.33 m | -£1.15 m | -£2.35 m |
| Cashflow before financing | -£415,000.00 | £2.56 m | -£1.01 m | -£2.42 m |
| Increase in Cash | -£345,000.00 | £2.48 m | -£1.49 m | -£3.33 m |
| Income | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Turnover | £4.11 m | £2.19 m | £2.18 m | £1.63 m |
| Cost of sales | £941,000.00 | £415,000.00 | £388,000.00 | £267,000.00 |
| Gross Profit | £3.17 m | £1.78 m | £1.79 m | £1.36 m |
| Operating Profit | -£20,000.00 | -£1.94 m | -£2.31 m | -£2.35 m |
| Pre-Tax profit | -£10,000.00 | -£2.02 m | -£2.32 m | -£2.36 m |
Rua Life Sciences PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | RUA Life Sciences PLC is engaged in contract design and manufacture of medical devices and exploiting the value of its IP and know-how, and developing of cardiovascular devices. Its segments include Biomaterials includes Licensor of Elast-Eon polymers to the medical device industry; Medical Devices and Components engages End-to-end contract developer, manufacturer, and seller of medical devices and implantable fabric specialist; Vascular engages in the development and commercialization of the group's Elast-Eon sealed Vascular Graft products; and Structural Heart engages in the development of the group's Elast-Eon composite heart valve material AurTex. Geographically it operates in Europe, North America, MiddleEast , Asia Pacific, and Africa. |
| Latest Interim Date | 11 Dec 2024 |
| Latest Fiscal Year End Date | 24 Jul 2024 |
Rua Life Sciences PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2020-12-11 | Mr. James Gordon Wright | Non-Executive Director |
| 2013-12-03 | Mr. Francis Patrick Maguire | Executive Director,Chief Executive |
| 2012-12-31 | Mr. Jonathan Peter Pither | Non-Executive Director |
| 2024-07-26 | Mr. Ian Leslie Ardill | Non-Executive Director |
| 2016-10-31 | Mr. Edward Eddie McDaid | Executive Director,Chief Executive Officer |
| 2025-02-04 | Mr. William Donald Brown | Executive Director,Chief Executive Officer |
| 2011-10-21 | Dr. Stuart Bernard Rollason | Non-Executive Director |
| 2015-06-01 | Mr. Roy Walter Mitchell | Non-Executive Director,Finance Director |
| 2024-07-26 | Mr. John McKenna | Non-Executive Director |
| 2024-07-26 | Mr. John Louis Ely | Non-Executive Director |
| 2024-07-26 | Mr. Geoffrey Alan Berg | Non-Executive Director,Chairman |
| 2021-08-10 | Mr. David Muir Richmond | Executive Director,Chief Executive Officer |
| 2024-07-26 | Dr. Caroline Stretton | Executive Director,Managing Director |
| 2025-05-06 | Mr. Lachlan Arthur Smith | Executive Director,Company Secretary and Group Chief Financial Officer |
| 2024-07-26 | Dr. Iain Crawford Anthony | Executive Director,Director of Clinical and Regulatory Affairs |
Rua Life Sciences PLC Contact Details
| Company Name | RUA Life Sciences PLC |
|---|---|
| Address | c/o Kergan Stewart LLP, 163 Bath Street, Glasgow, G2 4SQ |
| Telephone | |
| Website | https://www.rualifesciences.com |
Rua Life Sciences PLC Advisors
| Registrar | Equiniti Limited |
|---|
| Stockbroker | FinnCap |
|---|---|
| Phone | +44 2072200500 |
| Fax | +44 2076001659 |
| Auditor | Grant Thornton UK LLP |
|---|---|
| Phone | (0116) 247 1234 |
| Fax | (0116) 247 1434 |
| Solicitor | DAC Beachcroft LLP |
|---|---|
| Phone | +44 2072421011 |
| Fax | +44 2078316630 |
| Solicitor | Brodies LLP |
|---|---|
| Phone | (0131) 228 3777 |
| Fax | (0131) 228 3878 |
| Bank | Bank of Scotland |
|---|
| Nominated Adviser | FinnCap |
|---|---|
| Phone | +44 2072200500 |
| Fax | +44 2076001659 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Itv PLC | 78.95 | 17.40 |
| Jtc PLC | 1,358.00 | 4.62 |
| Oxford Nanopore Technologies PLC | 140.00 | 4.87 |
| Hikma Pharmaceuticals PLC | 1,582.00 | 0.00 |
| Coca-Cola Europacific Partners PLC | 6,950.00 | 1.76 |
| Wpp PLC | 279.10 | 3.79 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Rightmove PLC | 573.60 | -13.59 |
| International Consolidated Airlines Group S.A. | 366.20 | -13.88 |
| Baltic Classifieds Group PLC | 263.50 | -8.51 |
| Me Group International PLC | 175.00 | -8.47 |
| Auto Trader Group PLC | 751.20 | -5.27 |
| Ceres Power Holdings PLC | 354.80 | -4.57 |
Risers/fallers data from previous trading day.